Metabolic dysfunction- associated steatohepatitis, or MASH, is an inflammatory, liver-scarring disease that has reached epidemic proportions, with an estimated 1.5% to 6.5% of U.S. adults afflicted by ...
By recreating a fetal liver niche, FLOs show how liver and immune cells co-develop. Learn more about new groundbreaking ...
NORCROSS, Ga., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (GALT) (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback